Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
Büchner
T
T
Department of Medicine, University of Münster, Germany.
Hiddemann
W
W
Löffler
G
G
Gassmann
W
W
Maschmeyer
G
G
Heit
W
W
Hossfeld
D
D
Weh
H
H
Ludwig
W D
WD
Thiel
E
E
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin